EUR 741.00 For Business Accounts Only

Rx/Reimbursement Adult Incontinence in the Philippines

The Philippines saw Rx/reimbursement adult incontinence sales of PHP7.5 million in 2017, representing less than 1% of total adult incontinence value in the market in MSP terms. While the expansion of the healthcare industry and the significant growth in the mid-lifers (aged 45-64), later lifers (aged 65-79) and seniors (aged 80+) population groups provides a potential boost for Rx/reimbursement adult incontinence, the growth of both retail and AFH adult incontinence is likely to militate agains...

Euromonitor International's Rx/Reimbursement adult incontinence in Philippines report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2013-2017, allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market – be they new product developments, distribution or pricing issues. Forecasts to 2022 illustrate how the market is set to change.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Rx/Reimbursement adult incontinence market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.